Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Harbarth

Showing results (41-50 of 146) with videos related to

Pageof 15
Sort By:
Journal of Clinical Pharmacy and Therapeutics|October 2, 1998
Cefepime--assessment of its need at a tertiary care centerS Harbarth, D Pittet, V Gabriel, et al.
The Journal of Hospital Infection|December 15, 2007
Multi-resistant infections in repatriated patients after natural disasters: lessons learned from the 2004 tsunami for hospital infection controlI Uçkay, H Sax, S Harbarth, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 13, 2015
Education in infection control: A need for European certificationW Zingg, N T Mutters, S Harbarth, et al.
The Journal of Hospital Infection|May 19, 2001
Variation in nosocomial infection prevalence according to patient care setting:a hospital-wide surveyH Sax, S Hugonnet, S Harbarth, et al.
Schweizerische Medizinische Wochenschrift|November 24, 1999
Nosocomial infections in Swiss university hospitals: a multi-centre survey and review of the published experience. Swiss-Noso NetworkS Harbarth, C Ruef, P Francioli, et al.
BMC Infectious Diseases|July 27, 2001
The estimated economic burden of genital herpes in the United States. An analysis using two costing approachesT D Szucs, K Berger, D N Fisman, et al.
Intensive Care Medicine|November 1, 2018
Adaptive designs in clinical trials in critically ill patients: principles, advantages and pitfallsC H van Werkhoven, S Harbarth, M J M Bonten
Schweizerische Medizinische Wochenschrift|March 22, 1997
[Inter- and intrahospital transmission of methicillin-resistant Staphylococcus aureus]S Harbarth, J Romand, R Frei, et al.
The Journal of Hospital Infection|July 6, 2014
Is reduced susceptibility to disinfectants and antiseptics a risk in healthcare settings? A point/counterpoint reviewS Harbarth, S Tuan Soh, C Horner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2001
Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilliS Harbarth, A D Harris, Y Carmeli, et al.
Pageof 15

Showing results (41-50 of 146) with videos related to

Sort By:
Pageof 15
Journal of Clinical Pharmacy and Therapeutics|October 2, 1998
Cefepime--assessment of its need at a tertiary care centerS Harbarth, D Pittet, V Gabriel, et al.
The Journal of Hospital Infection|December 15, 2007
Multi-resistant infections in repatriated patients after natural disasters: lessons learned from the 2004 tsunami for hospital infection controlI Uçkay, H Sax, S Harbarth, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 13, 2015
Education in infection control: A need for European certificationW Zingg, N T Mutters, S Harbarth, et al.
The Journal of Hospital Infection|May 19, 2001
Variation in nosocomial infection prevalence according to patient care setting:a hospital-wide surveyH Sax, S Hugonnet, S Harbarth, et al.
Schweizerische Medizinische Wochenschrift|November 24, 1999
Nosocomial infections in Swiss university hospitals: a multi-centre survey and review of the published experience. Swiss-Noso NetworkS Harbarth, C Ruef, P Francioli, et al.
BMC Infectious Diseases|July 27, 2001
The estimated economic burden of genital herpes in the United States. An analysis using two costing approachesT D Szucs, K Berger, D N Fisman, et al.
Intensive Care Medicine|November 1, 2018
Adaptive designs in clinical trials in critically ill patients: principles, advantages and pitfallsC H van Werkhoven, S Harbarth, M J M Bonten
Schweizerische Medizinische Wochenschrift|March 22, 1997
[Inter- and intrahospital transmission of methicillin-resistant Staphylococcus aureus]S Harbarth, J Romand, R Frei, et al.
The Journal of Hospital Infection|July 6, 2014
Is reduced susceptibility to disinfectants and antiseptics a risk in healthcare settings? A point/counterpoint reviewS Harbarth, S Tuan Soh, C Horner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2001
Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilliS Harbarth, A D Harris, Y Carmeli, et al.
Pageof 15